Contact
searchSearch
HMP Global

Volume 24 - Issue 7 - July 2016

CLI Perspectives
CLI and Low-Profile Devices: Have We Reached a Device Paradigm Shift?
07/09/2016
Jihad A. Mustapha, MD, FACC, FSCAI
This month, Dr. Mustapha interviews Osamu Iida, MD, Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
This month, Dr. Mustapha interviews Osamu Iida, MD, Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
This month, Dr. Mustapha...
07/09/2016
Cath Lab Digest
Cath Lab Safety
Patient Safety in the Cath Lab: A Team Sport Part II of III
07/09/2016
Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Healthcare is, like most complex human activities, a team sport. There are many aspects to effective teams including a common purpose, mutual respect, effective leadership and conflict resolution, good communication, situational awareness,...
Healthcare is, like most complex human activities, a team sport. There are many aspects to effective teams including a common purpose, mutual respect, effective leadership and conflict resolution, good communication, situational awareness,...
Healthcare is, like most complex...
07/09/2016
Cath Lab Digest
Meeting Update
News: VentureMed Group Announces FDA Approval of FLEX Scoring Catheter
07/09/2016
Flex is a cost-effective alternative to balloon-based scoring with a one-size-fits-all platform technology. The vessel-preparation device provides for effective dynamic linear scoring with a lower propensity for barotrauma or vessel wall...
Flex is a cost-effective alternative to balloon-based scoring with a one-size-fits-all platform technology. The vessel-preparation device provides for effective dynamic linear scoring with a lower propensity for barotrauma or vessel wall...
Flex is a cost-effective...
07/09/2016
Cath Lab Digest
Meeting Update
News: One-Third of Patients With Low Flow Aortic Stenosis Do Not Improve With TAVR, Research Finds
07/09/2016
Patients who do not improve with TAVR are found to have worse clinical outcomes at 1 year.
Patients who do not improve with TAVR are found to have worse clinical outcomes at 1 year.
Patients who do not improve with...
07/09/2016
Cath Lab Digest
Meeting Update
News: Meta-Analysis: Radial Access Should be Default Approach
07/09/2016
When inserting stents to restore blood flow in heart disease patients, radial access has fewer complications and should be the default approach over femoral access, according to researchers.
When inserting stents to restore blood flow in heart disease patients, radial access has fewer complications and should be the default approach over femoral access, according to researchers.
When inserting stents to restore...
07/09/2016
Cath Lab Digest
Value in the Cath Lab: Contemporary Use of GP IIb/IIIa Inhibitors in the Treatment of ACS at the Mayo Clinic Heath System
07/09/2016
Eric H. Yang, MD
In terms of choosing which GP IIb/IIIa inhibitor to use, what historically has just been a two-person game, is now a three-person game that includes abciximab, eptifibatide, and tirofiban.
In terms of choosing which GP IIb/IIIa inhibitor to use, what historically has just been a two-person game, is now a three-person game that includes abciximab, eptifibatide, and tirofiban.
In terms of choosing which GP...
07/09/2016
Cath Lab Digest
Interventional Treatment of Deep Vein Thrombosis (DVT) at St. Charles Hospital
07/07/2016
Jason P. Jundt, MD; Wayne K. Nelson, MD, FACS, RPVI
We have an opportunity to make a meaningful difference, acutely, with relief of pain and swelling, restoration to ambulation, and occasionally, limb preservation. Aggressive treatment of DVT using devices can also minimize the risk of...
We have an opportunity to make a meaningful difference, acutely, with relief of pain and swelling, restoration to ambulation, and occasionally, limb preservation. Aggressive treatment of DVT using devices can also minimize the risk of...
We have an opportunity to make a...
07/07/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
Percutaneous Valve Innovations: Tricuspid Valve Intervention
07/07/2016
Azeem Latib, MD, BCh, MBBCh
A number of physicians in the world, working alongside some startup companies, have identified an unmet need. We need devices that are percutaneous in order to treat these patients, because they get to a point where surgery is extremely high...
A number of physicians in the world, working alongside some startup companies, have identified an unmet need. We need devices that are percutaneous in order to treat these patients, because they get to a point where surgery is extremely high...
A number of physicians in the...
07/07/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
Percutaneous Valve Innovations: Transcatheter Mitral Valve Intervention
07/07/2016
Ted Feldman, MD, FSCAI, FACC, FESC
The mitral valve orifice is much bigger than the aortic valve orifice. It is D-shaped, so creating a replacement prosthesis for the mitral valve requires a much bigger device and a much more complex geometry. That is one of the challenges of...
The mitral valve orifice is much bigger than the aortic valve orifice. It is D-shaped, so creating a replacement prosthesis for the mitral valve requires a much bigger device and a much more complex geometry. That is one of the challenges of...
The mitral valve orifice is much...
07/07/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
Percutaneous Valve Innovations: Transcatheter Aortic Valve Replacement
07/07/2016
Didier Tchetche, MD
Clinique Pasteur in Toulouse is the lead center in France for interventional cardiology and cardiology in general, with more than 3000 percutaneous coronary interventions (PCI) per year. I am the head of the structural heart disease program...
Clinique Pasteur in Toulouse is the lead center in France for interventional cardiology and cardiology in general, with more than 3000 percutaneous coronary interventions (PCI) per year. I am the head of the structural heart disease program...
Clinique Pasteur in Toulouse is...
07/07/2016
Cath Lab Digest
CRF-SKIRBALL Interventional Innovation Corner
Percutaneous Valve Innovations
07/06/2016
CRF-Skirball Interventional Innovation Corner, with section editor Juan F. Granada, MD.
CRF-Skirball Interventional Innovation Corner, with section editor Juan F. Granada, MD.
CRF-Skirball Interventional...
07/06/2016
Cath Lab Digest
Cath Lab Spotlight
Spotlight: The Cardiac Catheterization Laboratory at the University of North Carolina Medical Center, Chapel Hill
07/06/2016
Prashant Kaul, MD, FACC, FSCAI; Reginald L. Erwin, RCIS; Brenda McClure, RN, BSN; Cathy Rege, RN, MS
Our median time from arrival to primary PCI for the last 12 months was 38 minutes for patients presenting directly to UNC. For patients transferred from other non-PCI capable facilities, our median time from arrival at the referral facility...
Our median time from arrival to primary PCI for the last 12 months was 38 minutes for patients presenting directly to UNC. For patients transferred from other non-PCI capable facilities, our median time from arrival at the referral facility...
Our median time from arrival to...
07/06/2016
Cath Lab Digest
Clinical Editor's Corner
Can No-Reflow Be Silent?
07/06/2016
Morton J. Kern, MD, MSCAI, FACC, FAHA
No-reflow is usually a devastating complication when treating the ST-elevation myocardial infarction (STEMI) patient or working with saphenous vein graft (SVG) interventions. Fortunately, it’s uncommon for elective procedures. We recently had...
No-reflow is usually a devastating complication when treating the ST-elevation myocardial infarction (STEMI) patient or working with saphenous vein graft (SVG) interventions. Fortunately, it’s uncommon for elective procedures. We recently had...
No-reflow is usually a...
07/06/2016
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Neurovascular acquisitions
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/11/2026
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform...
03/11/2026
Cath Lab Digest
EggNest (Egg Medical)
Clinical Trial Update
Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection
03/10/2026
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we...
03/10/2026
EP Lab Digest
CathWorks FFRangio
Fractional Flow Reserve
Late-Breaking Trial: U.S. Cohort of 4,000+ CathWorks FFRangio Patients Shows 2-Year Outcomes Comparable to Pressure Wire–Guided PCI
03/08/2026
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary...
03/08/2026
Cath Lab Digest
Heart Failure
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
03/04/2026
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that...
03/04/2026
Cath Lab Digest
Heart Failure
Relief Cardiovascular Reports Positive First-in-Human Data for Device-Based Decongestion Therapy in Heart Failure Patients
03/04/2026
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
"The RELIEF-FIH study provides...
03/04/2026
Cath Lab Digest
Amputation Prevention
Researchers Develop New Oxygen-Delivering Gel Designed to Help Wounds Heal Before They Progress to Limb Loss
02/23/2026
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
A wound that remains open for...
02/23/2026
Cath Lab Digest
Nutrition
People Whose Sugar Intake Was Restricted Before Birth and In Early Childhood Had Markedly Lower Rates of Heart Disease Later In Life 
02/23/2026
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
Limiting sugar consumption...
02/23/2026
Cath Lab Digest
VentiV Mechanical Thrombectomy system illustration
Thrombectomy
FDA Clearance for VentiV Mechanical Thrombectomy System Brings New “Pulse” Platform to Peripheral Clot Removal
02/23/2026
SALT LAKE CITY, UT  — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. Blood clot removal...
SALT LAKE CITY, UT  — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. Blood clot removal...
SALT LAKE CITY, UT ...
02/23/2026
Cath Lab Digest
Acute Coronary Syndromes
Acute Coronary Events Registry Provides Insights Into Sex-Specific Differences
02/20/2026
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – Preliminary...
02/20/2026
Cath Lab Digest

Volume 24 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use